ID

43531

Beschreibung

PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00605397

Link

https://clinicaltrials.gov/show/NCT00605397

Stichworte

  1. 08.06.17 08.06.17 -
  2. 20.09.21 20.09.21 -
Hochgeladen am

20. September 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT00605397

Eligibility Breast Cancer NCT00605397

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
registered patient at mskcc
Beschreibung

ID.1

Datentyp

boolean

Alias
UMLS CUI [1]
C1513120
age ≥18 years
Beschreibung

ID.2

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
patients with her2+ metastatic breast cancer (either 3+ by immunohistochemistry or with evidence of gene amplification (>2.0) by fluorescence in situ hybridization (fish))
Beschreibung

ID.3

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1960398
UMLS CUI [1,2]
C0027627
measurable or evaluable disease
Beschreibung

ID.4

Datentyp

boolean

Alias
UMLS CUI [1]
C0449385
currently taking or about to commence treatment with trastuzumab at a dosing schedule of 2 mg/kg weekly or 6 mg/kg every three weeks, as per standard of care
Beschreibung

ID.5

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0728747
karnofsky performance score ≥ 60
Beschreibung

ID.6

Datentyp

boolean

Alias
UMLS CUI [1]
C0206065
signed informed consent
Beschreibung

ID.7

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous grade 3 or higher allergic reaction to trastuzumab that resulted in discontinuation of trastuzumab therapy
Beschreibung

ID.8

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0728747
claustrophobia/pain leading to inability to lie still for the duration of the scanning procedure.
Beschreibung

ID.9

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0008909
UMLS CUI [1,2]
C0024485
pregnancy test to be performed on female patients of childbearing potential within 24hrs before administration of radioactive material.
Beschreibung

ID.10

Datentyp

boolean

Alias
UMLS CUI [1]
C0032976
inability to provide written informed consent.
Beschreibung

ID.11

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
patients with liver metastases as the only site of distant disease
Beschreibung

ID.12

Datentyp

boolean

Alias
UMLS CUI [1]
C0494165
patients with known sensitivity or contraindication to herceptin.
Beschreibung

ID.13

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0338204

Ähnliche Modelle

Eligibility Breast Cancer NCT00605397

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
registered patient at mskcc
boolean
C1513120 (UMLS CUI [1])
ID.2
Item
age ≥18 years
boolean
C0001779 (UMLS CUI [1])
ID.3
Item
patients with her2+ metastatic breast cancer (either 3+ by immunohistochemistry or with evidence of gene amplification (>2.0) by fluorescence in situ hybridization (fish))
boolean
C1960398 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
ID.4
Item
measurable or evaluable disease
boolean
C0449385 (UMLS CUI [1])
ID.5
Item
currently taking or about to commence treatment with trastuzumab at a dosing schedule of 2 mg/kg weekly or 6 mg/kg every three weeks, as per standard of care
boolean
C0013216 (UMLS CUI [1,1])
C0728747 (UMLS CUI [1,2])
ID.6
Item
karnofsky performance score ≥ 60
boolean
C0206065 (UMLS CUI [1])
ID.7
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.8
Item
previous grade 3 or higher allergic reaction to trastuzumab that resulted in discontinuation of trastuzumab therapy
boolean
C0020517 (UMLS CUI [1,1])
C0728747 (UMLS CUI [1,2])
ID.9
Item
claustrophobia/pain leading to inability to lie still for the duration of the scanning procedure.
boolean
C0008909 (UMLS CUI [1,1])
C0024485 (UMLS CUI [1,2])
ID.10
Item
pregnancy test to be performed on female patients of childbearing potential within 24hrs before administration of radioactive material.
boolean
C0032976 (UMLS CUI [1])
ID.11
Item
inability to provide written informed consent.
boolean
C0021430 (UMLS CUI [1])
ID.12
Item
patients with liver metastases as the only site of distant disease
boolean
C0494165 (UMLS CUI [1])
ID.13
Item
patients with known sensitivity or contraindication to herceptin.
boolean
C0020517 (UMLS CUI [1,1])
C0338204 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video